HRP20050917A2 - Process for preparing crystalline ciclesonide with defined particle size - Google Patents

Process for preparing crystalline ciclesonide with defined particle size

Info

Publication number
HRP20050917A2
HRP20050917A2 HR20050917A HRP20050917A HRP20050917A2 HR P20050917 A2 HRP20050917 A2 HR P20050917A2 HR 20050917 A HR20050917 A HR 20050917A HR P20050917 A HRP20050917 A HR P20050917A HR P20050917 A2 HRP20050917 A2 HR P20050917A2
Authority
HR
Croatia
Prior art keywords
particle size
crystalline ciclesonide
pharmaceutical compositions
preparing crystalline
defined particle
Prior art date
Application number
HR20050917A
Other languages
English (en)
Inventor
Schmidt Beate
Kaupp Stefan
Sturm Ernst
Eistetter Klaus
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33099298&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20050917(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of HRP20050917A2 publication Critical patent/HRP20050917A2/xx
Publication of HRP20050917B1 publication Critical patent/HRP20050917B1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
    • B01F21/00—Dissolving

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Izum se odnosi na nove postupke za dobivanje kristaliničnog ciklesonida s pogodnom veličinom čestica i raspodjelom veličine čestica i na njegovu upotrebu u proizvodnji farmaceutskih pripravaka, posebice za topikalnu upotrebu. Kristalinični ciklesonid dobiven novim postupkom ima povoljna aerodinamička svojstva, i može se dalje procesirati u inhalacijske farmaceutske pripravke ili farmaceutske pripravke za nazalnu primjenu, bez daljnje mehaničke mikronizacije.
HRP20050917AA 2003-03-27 2005-10-19 Postupak za dobivanje kristaliniäśnog ciklesonida s definiranom veliäśinom äśestica HRP20050917B1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03007007 2003-03-27
DE10314097 2003-03-27
PCT/EP2004/050373 WO2004085460A1 (en) 2003-03-27 2004-03-26 Process for preparing crystalline ciclesonide with defined particle size

Publications (2)

Publication Number Publication Date
HRP20050917A2 true HRP20050917A2 (en) 2006-12-31
HRP20050917B1 HRP20050917B1 (hr) 2014-02-14

Family

ID=33099298

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20050917AA HRP20050917B1 (hr) 2003-03-27 2005-10-19 Postupak za dobivanje kristaliniäśnog ciklesonida s definiranom veliäśinom äśestica

Country Status (28)

Country Link
US (1) US9422327B2 (hr)
EP (1) EP1611150B1 (hr)
JP (1) JP4746535B2 (hr)
KR (1) KR101102709B1 (hr)
AR (1) AR043579A1 (hr)
AT (1) ATE546459T1 (hr)
AU (1) AU2004224092B2 (hr)
BR (1) BRPI0408569B1 (hr)
CA (1) CA2519752C (hr)
CL (1) CL2004000636A1 (hr)
CY (1) CY1112970T1 (hr)
DK (1) DK1611150T3 (hr)
EA (1) EA011157B1 (hr)
ES (1) ES2382928T3 (hr)
HK (1) HK1088905A1 (hr)
HR (1) HRP20050917B1 (hr)
IL (1) IL170746A (hr)
MX (1) MXPA05010041A (hr)
MY (1) MY143936A (hr)
NO (1) NO331984B1 (hr)
NZ (1) NZ542827A (hr)
PE (1) PE20050388A1 (hr)
PL (1) PL1611150T3 (hr)
PT (1) PT1611150E (hr)
RS (1) RS52549B (hr)
SI (1) SI1611150T1 (hr)
TW (1) TWI328589B (hr)
WO (1) WO2004085460A1 (hr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
EP1869064A2 (en) * 2005-11-02 2007-12-26 Sicor, Inc. Improved process for the preparation of ciclesonide
CA2637815A1 (en) * 2006-02-08 2007-08-16 Sicor Inc. Crystalline forms of ciclesonide
WO2008015696A2 (en) * 2006-05-23 2008-02-07 Cadila Healthcare Limited Process for preparing ciclesonide
WO2008062450A2 (en) * 2006-09-18 2008-05-29 Cadila Healthcare Limited Crystalline polymorphs of ciclesonide
KR20090078329A (ko) * 2006-09-19 2009-07-17 씨아이피엘에이 엘티디. 시클레소니드의 제조방법 및 그의 결정형
PT2262823E (pt) * 2008-03-13 2013-03-05 Farmabios Spa Processo para a preparação de derivados de pregnano
IT1397499B1 (it) * 2009-01-09 2013-01-16 Farmabios Spa Processo per la preparazione di ciclesonide
WO2010054158A2 (en) * 2008-11-07 2010-05-14 Auspex Pharmaceuticals, Inc. Steroid modulators of glucocorticoid receptor
US9109005B2 (en) 2012-02-23 2015-08-18 Boehringer Ingelheim International Gmbh Method for manufacturing of ciclesonide
WO2014007772A2 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions comprising glucose anhydrous
US20150165037A1 (en) 2012-07-05 2015-06-18 Arven llac Sanayi Ve Ticaret A.S. Inhalation compositions comprising corticosteroid and sorbitol
WO2014007781A2 (en) 2012-07-05 2014-01-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Inhalation compositions
PL3464318T3 (pl) 2016-06-02 2021-11-08 Abbvie Inc. Agonista receptora glukokortykoidowego i jego immunokoniugaty
KR20200095477A (ko) 2017-12-01 2020-08-10 애브비 인코포레이티드 글루코코르티코이드 수용체 작용제 및 이의 면역접합체

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8328929D0 (en) 1983-10-29 1983-11-30 Sterwin Ag Steroid compounds
EP0437451B1 (en) 1988-10-05 1993-06-09 The Upjohn Company Finely divided solid crystalline powders via precipitation into an anti-solvent
ES2060040T5 (es) 1989-05-31 1999-09-16 Fisons Plc Dispositivo y formulacion de inhalacion de medicamento.
GR1001529B (el) * 1990-09-07 1994-03-31 Elmuquimica Farm Sl Μέ?οδος για την λήψη νέων 21-εστέρων της 16-17-ακετάλης της πρ να-1,4-διενο-3,20-διόνης.
FR2668945B1 (fr) 1990-11-12 1993-02-19 Theramex Nouveau procede de cristallisation des substances organiques et les composes ainsi obtenus.
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
GB9213874D0 (en) 1992-06-30 1992-08-12 Fisons Plc Process to novel medicament form
GB9306703D0 (en) 1993-03-31 1993-05-26 Fisons Plc Inhalation device
ATE172739T1 (de) * 1993-04-02 1998-11-15 Byk Gulden Lomberg Chem Fab Neue prednisolonderivate
IL111194A (en) 1993-10-08 1998-02-08 Fisons Plc Process for the production of drug patramulations
AU697541B2 (en) * 1994-03-09 1998-10-08 Takeda Gmbh Novel silyl compounds and their use
DE19541689A1 (de) 1994-11-14 1996-05-15 Byk Gulden Lomberg Chem Fab Kombinationsarzneimittel
DE19635498A1 (de) 1996-09-03 1998-03-26 Byk Gulden Lomberg Chem Fab Verfahren zur Epimerenanreicherung
US6120752A (en) * 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
GB9722285D0 (en) 1997-10-23 1997-12-17 Rhone Poulenc Rorer Ltd Inhalation device
US6264923B1 (en) * 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
CA2338753C (en) * 1998-07-24 2006-11-21 Jago Research Ag Medicinal aerosol formulations
GB9828721D0 (en) * 1998-12-24 1999-02-17 Glaxo Group Ltd Novel apparatus and process
JP2003516115A (ja) * 1999-06-25 2003-05-13 コグニス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング ナノスケールステロールおよびステロールエステルの使用
AR026072A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
AR026073A1 (es) 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
CZ303885B6 (cs) 2000-11-10 2013-06-12 Takeda Gmbh Zpusob výroby 16,17-[(cyklohexylmethylen)bis(oxy)]-11,21-dihydroxypregna-1,4-dien-3,20-dionu nebo jeho 21-isobutyrátu

Also Published As

Publication number Publication date
MY143936A (en) 2011-07-29
PT1611150E (pt) 2012-05-07
CY1112970T1 (el) 2016-04-13
HRP20050917B1 (hr) 2014-02-14
HK1088905A1 (en) 2006-11-17
JP2006521332A (ja) 2006-09-21
ES2382928T3 (es) 2012-06-14
BRPI0408569A (pt) 2006-03-21
DK1611150T3 (da) 2012-05-14
PL1611150T3 (pl) 2012-07-31
RS52549B (en) 2013-04-30
NO20054835L (no) 2005-10-19
TW200418519A (en) 2004-10-01
NO331984B1 (no) 2012-05-21
US9422327B2 (en) 2016-08-23
KR101102709B1 (ko) 2012-01-05
EA011157B1 (ru) 2009-02-27
EP1611150A1 (en) 2006-01-04
ATE546459T1 (de) 2012-03-15
CA2519752A1 (en) 2004-10-07
BRPI0408569B1 (pt) 2017-08-29
AU2004224092B2 (en) 2010-03-04
PE20050388A1 (es) 2005-05-30
JP4746535B2 (ja) 2011-08-10
AU2004224092A1 (en) 2004-10-07
SI1611150T1 (sl) 2012-06-29
NZ542827A (en) 2008-02-29
IL170746A (en) 2012-06-28
WO2004085460A1 (en) 2004-10-07
TWI328589B (en) 2010-08-11
CL2004000636A1 (es) 2005-02-04
CA2519752C (en) 2012-05-29
WO2004085460A8 (en) 2007-03-15
KR20050114250A (ko) 2005-12-05
EA200501391A1 (ru) 2006-06-30
IL170746A0 (en) 2009-02-11
RS20050704A (en) 2007-06-04
EP1611150B1 (en) 2012-02-22
US20060128954A1 (en) 2006-06-15
AR043579A1 (es) 2005-08-03
MXPA05010041A (es) 2005-11-17

Similar Documents

Publication Publication Date Title
HRP20050917A2 (en) Process for preparing crystalline ciclesonide with defined particle size
Hu et al. Traditional uses, origins, chemistry and pharmacology of Bombyx batryticatus: a review
BR112015023629A2 (pt) formulação de acetato de abiraterona
WO2008058547A3 (en) Alpha-lactalbumin composition
EP1935892A4 (en) GLYCYRRHETINIC ACID-30-AMIDE ACID DERIVATIVES AND APPLICATIONS
WO2007124153A3 (en) Water-soluble pharmaceutical compositions of hops resins
MY175804A (en) Estra-1,3,5(10),16-tetraene-3-carboxamide derivatives, process for preparation thereof, pharmaceutical preparations comprising them, and use thereof for production of medicaments
UA104988C2 (uk) Похідні піроніндолу та спосіб їх отримання
TN2015000007A1 (en) 3-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments
MX2014004364A (es) Composiciones que comprenden sulfato de salbutamol.
CA2436540A1 (en) Pharmaceutical compositions based on anticholinergics and corticosteroids
CN103463188A (zh) 一种止痒凝露及其制备方法
US20150174245A1 (en) Transparent gel
CN101474141A (zh) 纳米中药牙膏的制作方法
CN108126045B (zh) 一种纳米二氧化硅复方中药及其应用
CN102526104A (zh) 一种复方治疗脚气药液及其制备方法
MX2012008861A (es) Composicion farmaceutica con actividad antiobesidad que comprende una premezcla de orlistat puro y proceso de preparacion.
CN103156913A (zh) 一种用于疏散表邪清热化湿的中药药物组合及其制备方法
AU2011304261A8 (en) Antimicrobial and anti-inflammatory action pharmaceutical composition for parenteral administration, process of producing the same
WO2010095158A8 (en) Pharmaceutical composition containing microcolloidal silver and carboxymethyl beta glucan for disinfection of the nasal mucosae, and process for preparation thereof
Muniyappan et al. Synthesis of Silver Nanoparticles Using Dalbergia rubiginosa Root Aqueous Extract
UA95690C2 (ru) Способ получения средства с диуретическим и противовоспалительным действием из листьев березы
CN103655323A (zh) 一种透明质酸修护乳
CN102949316A (zh) 一种甲壳素润肤液
CN1679723A (zh) 一种脚气膏

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: NYCOMED GMBH, DE

PNAN Change of the applicant name, address/residence

Owner name: TAKEDA GMBH, DE

B1PR Patent granted
PNAN Change of the applicant name, address/residence

Owner name: NYCOMED ASSET MANAGEMENT GMBH, DE

Owner name: NYCOMED GERMANY HOLDING GMBH, DE

Owner name: TAKEDA GMBH, DE

PPPP Transfer of rights

Owner name: ASTRAZENECA AB, SE

ODRP Renewal fee for the maintenance of a patent

Payment date: 20190207

Year of fee payment: 16

PPPP Transfer of rights

Owner name: COVIS PHARMA B.V., CH

ODRP Renewal fee for the maintenance of a patent

Payment date: 20200206

Year of fee payment: 17

ODRP Renewal fee for the maintenance of a patent

Payment date: 20210326

Year of fee payment: 18

ODRP Renewal fee for the maintenance of a patent

Payment date: 20220324

Year of fee payment: 19

PPPP Transfer of rights

Owner name: COVIS PHARMA GMBH, CH

ODRP Renewal fee for the maintenance of a patent

Payment date: 20230207

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20240326